Saturday, September 22, 2018

© Reuters.  Washington © Reuters. Washington “noise” a buying opportunity for Centene – Morgan Stanley

  • The selloff in Centene (CNC -4.5%) from the Trump administration’s plan to terminate health insurance subsidies to insurers is “exaggerated” according to Morgan Stanley (NYSE:MS). Shares were down almost 11% before before bargain hunters jumped in.
  • In note, analyst Gary Taylor says investors “misunderstood” the potential impact from the “Washington-driven noise,” citing expected legal challenges that will keep the money flowing and the fact that Centene has submitted two bids in most markets, one assuming cost-sharing reduction (CSR) subsidies and one without, with the ability to change mid-year if CSR funding changes.
  • Centene’s exchange exposure is only ~8%, with only 60% of those receiving CSRs.
  • He also reiterates that most states already asked insurers to load CSR costs into their 2018 bids or submit backup bids if the funding was discontinued.
  • Source: Bloomberg
  • Previously: Centene down 7% premarket on Trump order to end ACA subsidies (Oct. 13)
  • Now read: Valuation Dashboard: Healthcare – Update

Original article

sponsoredArticle = ‘div-gpt-ad-1466339494851-0’;

Banner Content